oa Editorial

Recent Patents on Drug Delivery & Formulation meets challenges to publish review and research articles, drug clinical trial studies with the major impact on recent patents on drug delivery and formulation. A content and overview of important and recent patents on drug delivery and formulation is included in the journal. The journal is essential reading for all researchers involved in the fields of drug delivery and formulation. The aims of RPDDF are certainly ambitious, for we pretend not only to attract the best researchers, nanotechnologists and pharmaceutical technologists worldwide working in drug formulation and drug delivery areas, but also to offer a magazine to the readers where the most advanced Biomedical pharmaceutical publications fit to print can be certain to be found. This requires the support of a prestigious house as Bentham Science, which we gratefully acknowledge, in particular to their very efficient and kind staff and professional Editors and assistants. We also are fortunate to count with a superb list of Editorial Board Members, all very distinguished professionals in their fields, and who shall ensure the quality of the material to be published. I believe this present issue truly represents the broad field that includes novel attractive approaches in the treatment of various biological disorders. Dr. Carlos Spuch et al. reviewed the intriguing topic of making advances in the treatment of neurodegenerative disorders employing nanoparticles. Nanotechnologies hold great promise in brain therapy as they protect the therapeutic agent and allow its sustained release; the nanoparticles can be used as gene delivery vehicles. In recent years, nanotechnology had patented new formulations and has evolved as a new treatment for brain diseases, especially for neurodegenerative diseases. The aim of this review was to summarize the last patents, clinical trials and news related with nanoparticles technology for the treatment of neurodegenerative diseases.....